(Q36895812)

16 August 2017

1 reference

title

Future of molecular profiling of human hepatocellular carcinoma (English)

1 reference

16 August 2017

Stephanie Roessler

1

1 reference

16 August 2017

Anuradha Budhu

series ordinal

2

1 reference

16 August 2017

Xin Wei Wang

series ordinal

3

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

3

1 reference

16 August 2017

issue

4

1 reference

16 August 2017

page(s)

429-439

1 reference

Global cancer statistics, 2002

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Translational strategies for cancer prevention in liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Hepatitis B virus biology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

cis-Activation of the human telomerase gene (hTERT) by the hepatitis B virus genome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Hepatitis B virus-related insertional mutagenesis implicates SERCA1 gene in the control of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

HBx gene of hepatitis B virus induces liver cancer in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Hepatitis B virus promotes hepatocarcinogenesis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Molecular pathogenesis of human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Involvement of Crm1 in hepatitis B virus X protein-induced aberrant centriole replication and abnormal mitotic spindles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Molecular mechanisms of hepatitis B virus-associated liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Present and future therapy for hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

The hepatitis B virus and common mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Hepatitis C virus infection: 10 years after the discovery of the virus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Genotyping of hepatitis B virus (HBV) by oligonucleotides microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Distinctive gene expression profiles associated with Hepatitis B virus x protein

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

A new strategy for defining critical functional groups on heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Hepatitis C virus biology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Different signaling pathways in the livers of patients with chronic hepatitis B or chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Primary liver cancer: worldwide incidence and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Resection and liver transplantation for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Recent advances of protein microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

The blood peptidome: a higher dimension of information content for cancer biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

α-fetoprotein: Reevaluation in hepatology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Cancer-associated molecular signature in the tissue samples of patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

cDNA microarray analysis of macroregenerative and dysplastic nodules in end-stage hepatitis C virus-induced cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Surgical therapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Is hepatic transplantation justified for primary liver cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Long-term survival after radiofrequency ablation of complex unresectable liver tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Radiofrequency ablation of liver tumors: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Genetic mechanisms of hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Hepatocellular carcinoma pathogenesis: from genes to environment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Review of genetic and epigenetic alterations in hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Cancer. Addiction to oncogenes--the Achilles heal of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Mechanisms of disease: Oncogene addiction--a rationale for molecular targeting in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Reversible tumorigenesis by MYC in hematopoietic lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Silencing of microRNAs in vivo with 'antagomirs'

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Genes associated with progression and recurrence of hepatocellular carcinoma in hepatitis C patients waiting and undergoing liver transplantation: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Friends or foes - bipolar effects of the tumour stroma in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Cytokines in cancer immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Integrative analysis of the cancer transcriptome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

Converting a breast cancer microarray signature into a high-throughput diagnostic test.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.4.429

21 January 2018

Identifiers

DOI

10.2217/14796694.3.4.429

1 reference

16 August 2017

1 reference